Is there a relationship between spondyloarthritis and periodontitis? A case–control study

Objective To compare the frequency and severity of periodontitis in patients with spondyloarthritis (SpA) with healthy control individuals, through the evaluation of clinical, serological and microbiological periodontal condition. Methods Patients with a diagnosis of SpA (n=78) and biological disease-modifying antirheumatic drug (bDMARD) naive fulfilling the Assessment of SpondyloArthritis international Society (ASAS) classification criteria as well as 156 healthy controls matched for age/gender were included. Two trained and calibrated periodontologists performed the periodontal clinical assessment. The presence of periodontitis and its severity were determined according to the criteria established by the Centers for Disease Control and Prevention-American Academy of Periodontology. The clinical periodontal variables, IgG1/IgG2 antibodies against Porphyromonas gingivalis andperiodontopathic bacterial identification, were also established. Comparisons of periodontal characteristics between the patients with SpA and the control group were performed using univariable analyses. A logistic regression analyses was performed to calculate the OR (95% CI) for diagnosis of periodontitis in patients with SpA and matched controls. Results A diagnosis of periodontitis was established in 56% in patients with SpA versus 69% of healthy controls (P≤ 0.01). Severe periodontitis was found in 3% versus 12% in SpA versus healthy controls, respectively (P≤ 0.01). There was no significant increase of frequency of any periodontal variable, IgG1/IgG2 antibodies against P. gingivalis or the presence of periodontopathic bacteria between patients with SpA and control group. Periodontitis was not positively associated with a diagnosis of SpA (OR: 0.57, 95% CI 0.32 to 1.00, P=0.05) in the logistic regression analyses. Conclusions We found a lower rather than a higher frequency and severity of periodontitis in patients with SpA in comparison with healthy control individuals. Our findings suggest that there is no positive association between SpA and periodontitis in Colombian patients.

[1]  P. Santos-Moreno,et al.  Is the Treatment with Biological or Non-biological DMARDS a Modifier of Periodontal Condition in Patients with Rheumatoid Arthritis? , 2017, Current rheumatology reviews.

[2]  J. Bello-Gualtero,et al.  Are obesity, ACPAs and periodontitis conditions that influence the risk of developing rheumatoid arthritis in first-degree relatives? , 2017, Clinical Rheumatology.

[3]  J. Bello-Gualtero,et al.  Periodontal Disease in Individuals With a Genetic Risk of Developing Arthritis and Early Rheumatoid Arthritis: A Cross-Sectional Study. , 2016, Journal of periodontology.

[4]  E. Rosenstein,et al.  Is there a link between carbamylation and citrullination in periodontal disease and rheumatoid arthritis? , 2015, Medical hypotheses.

[5]  G. Macfarlane,et al.  A possible link between ankylosing spondylitis and periodontitis: a systematic review and meta-analysis. , 2015, Rheumatology.

[6]  A. Boonen,et al.  Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis. , 2015, Annals of the rheumatic diseases.

[7]  I. McInnes,et al.  Influence of periodontal disease, Porphyromonas gingivalis and cigarette smoking on systemic anti-citrullinated peptide antibody titres. , 2013, Journal of clinical periodontology.

[8]  K. Üstün,et al.  Periodontal Disease in Patients with Psoriatic Arthritis , 2013, Inflammation.

[9]  P. Eke,et al.  Prevalence of Periodontitis in Adults in the United States: 2009 and 2010 , 2012, Journal of dental research.

[10]  G. Rutger Persson Rheumatoid arthritis and periodontitis – inflammatory and infectious connections. Review of the literature , 2012, Journal of oral microbiology.

[11]  D. M. van der Heijde,et al.  Endorsement of Definitions of Disease Activity States and Improvement Scores for the Ankylosing Spondylitis Disease Activity Score: Results from OMERACT 10 , 2011, The Journal of Rheumatology.

[12]  M. Dougados,et al.  The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general , 2010, Annals of the rheumatic diseases.

[13]  M. Dougados,et al.  Arthritis 2 Spondyloarthritis , 2011 .

[14]  K. Lundberg,et al.  Periodontitis in RA—the citrullinated enolase connection , 2010, Nature Reviews Rheumatology.

[15]  P. Schlattmann,et al.  Periodontal disease in patients with ankylosing spondylitis , 2009, Annals of the rheumatic diseases.

[16]  Thomas Dietrich,et al.  Periodontitis in systemic rheumatic diseases , 2009, Nature Reviews Rheumatology.

[17]  M. Dougados,et al.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection , 2009, Annals of the rheumatic diseases.

[18]  R. Biffar,et al.  Epidemiology of periodontal diseases in the Study of Health in Pomerania. , 2009, Journal of clinical periodontology.

[19]  T. Huizinga,et al.  Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets , 2008, Arthritis research & therapy.

[20]  T. McAlindon,et al.  Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. , 2008, The Journal of rheumatology.

[21]  M. Soory Periodontal diseases and rheumatoid arthritis: a coincident model for therapeutic intervention? , 2007, Current drug metabolism.

[22]  M. Stone,et al.  The assessment of ankylosing spondylitis in clinical practice , 2007, Nature Clinical Practice Rheumatology.

[23]  P. Eke,et al.  Case Definitions for Use in Population-Based Surveillance of Periodontitis. , 2007, Journal of periodontology.

[24]  Astrid Giraldo,et al.  Demographic, clinical, and microbial aspects of chronic and aggressive periodontitis in Colombia: a multicenter study. , 2007, Journal of periodontology.

[25]  T. Huizinga,et al.  The Devil in the Details: The Emerging Role of Anticitrulline Autoimmunity in Rheumatoid Arthritis , 2005, The Journal of Immunology.

[26]  Salvi Ge,et al.  The effects of non-steroidal anti-inflammatory drugs (selective and non-selective) on the treatment of periodontal diseases. , 2005, Current pharmaceutical design.

[27]  N. Lang,et al.  The effects of non-steroidal anti-inflammatory drugs (selective and non-selective) on the treatment of periodontal diseases. , 2005, Current pharmaceutical design.

[28]  P. Savelkoul,et al.  Comparison of Real-Time PCR and Culture for Detection of Porphyromonas gingivalis in Subgingival Plaque Samples , 2003, Journal of Clinical Microbiology.

[29]  R. Page,et al.  The pathogenesis of human periodontitis: an introduction. , 1997, Periodontology 2000.

[30]  T. H. Howell,et al.  Nonsteroidal antiinflammatory drugs as inhibitors of periodontal disease progression. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[31]  R. H. Johnson,et al.  Assessment of the efficacy of a nonsteroidal anti-inflammatory drug, Naprosyn, in the treatment of gingivitis. , 1990, Journal of periodontal research.

[32]  L. Schneider,et al.  The effects of topical steroidal and systemic nonsteroidal anti-inflammatory drugs on experimental gingivitis in man. , 1984, Journal of periodontology.